Lipoxin A4 Mimetics Formulation at Basic pH for Stable Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for synthesizing lipoxin analogs are inefficient, result in low product yields, and are costly to stabilize, making them unsuitable for effective treatment of periodontal disease and inflammatory conditions.
Innovation Solution
A method for synthesizing lipoxin A4 mimetics with increased stability in basic pH environments, using specific structural formulas and reaction steps to achieve yields greater than 50%, and formulating these compounds into pharmaceutical compositions with pH greater than 7 to minimize degradation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional synthesis methods are used for lipoxin analogs, then the compounds can be produced, but the product yields are low and the synthesis is costly
Solution Approach 1:
The patent changes the pH parameter of the synthesis environment to basic conditions (pH > 7), which dramatically improves the stability and yield of lipoxin analogs. This parameter change transforms the synthesis from an inefficient process with low yields to a cost-effective method achieving greater than 50% yields, directly resolving the contradiction between productivity and ease of manufacture
Solution Approach 2:
Instead of using traditional acidic or neutral synthesis conditions that result in low yields and high costs, the patent inverts the approach by employing basic pH conditions. This inversion of the conventional synthesis paradigm leads to improved product stability, higher yields, and reduced manufacturing costs
2Reliability
If lipoxin analogs are synthesized using conventional methods, then the compounds are produced, but they require costly stabilization measures
Solution Approach 1:
The patent employs basic pH conditions (pH > 7) as a stabilizing parameter that inherently protects lipoxin analogs from degradation. This eliminates the need for costly additional stabilization measures while maintaining high compound stability and reliability throughout storage and treatment
3Manufacturing precision
If multiple synthetic steps are used to create lipoxin analogs, then the desired molecular structure is achieved, but the overall yield decreases
Solution Approach 1:
The patent applies basic pH conditions across multiple synthetic steps, which maintains high stability and reactivity throughout the synthesis sequence. This parameter optimization ensures that each step achieves high conversion efficiency, maintaining manufacturing precision while maximizing overall product yield
Data Source
AI summary
This disclosure relates to methods of synthesizing certain lipoxin analogs (e.g., lipoxin mimetics, etc.) and pharmaceutical compositions comprising these pro-resolving compounds. Methods of administering the lipoxin mimetics (e.g., lipoxin A4 mimetics, lipoxin B4 mimetics, etc.) to patients in need thereof are also provided.